-
公开(公告)号:EP3386523A1
公开(公告)日:2018-10-17
申请号:EP16820183.8
申请日:2016-12-09
IPC分类号: A61K35/745
CPC分类号: A61K35/745 , A23L33/135 , A23L33/30 , A23V2002/00 , A23V2200/3204 , A23V2200/332 , A61P3/04 , C12N1/20 , C12R1/01
摘要: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
-
公开(公告)号:EP3386478A1
公开(公告)日:2018-10-17
申请号:EP15848140.8
申请日:2015-12-31
申请人: UAB "Probiosanus"
IPC分类号: A61K8/99 , A61Q19/00 , A61K8/11 , A23L33/135 , A61Q19/10
CPC分类号: A61K8/11 , A23L33/135 , A61K8/416 , A61K8/463 , A61K8/731 , A61K8/733 , A61K8/922 , A61K8/9789 , A61K8/99 , A61K2800/41 , A61K2800/48 , A61K2800/52 , A61K2800/596 , A61K2800/74 , A61Q19/10
摘要: Disclosed is an approach for probiotic bacteria preservation and protection in the compositions of surface-active material containing personal hygiene/care product compositions. Probiotic bacteria (PB) are well known group of microorganisms for the beneficial effects on human health. Thus it is widely used as food and cosmetic, personal hygiene supplements (C/PHS). PB positive action within the compositions of cosmetics could be related with the complementation of human microbiome, production of various anti-oxidative, moisturizing, biocide activity possessing compounds or other fermentation products which are affecting human skin or other organ systems. In many cases Gram+ PB and/or PB bacterial metabolites are supplemented into detergent based personal care or domestic hygiene compositions to improve product functional features. The PB protection mechanism is based on bacterial immobilization/encapsulation into polymer pectin/alginate or alginate capsules which polymeric barrier allows maintaining of stable bacterial viability in the detergent based personal care or domestic hygiene products.
-
33.
公开(公告)号:EP3379945A1
公开(公告)日:2018-10-03
申请号:EP16816788.0
申请日:2016-11-22
IPC分类号: A23L33/10 , A61K31/716 , C08B37/00 , C12P19/04 , C12P19/08 , C12P19/16 , C12P19/18 , C12N9/10 , C08L5/00 , C08L5/02 , A23L33/135 , A23L33/21 , A61K8/73
CPC分类号: C07K14/4725 , A23L33/10 , A23L33/135 , A23L33/21 , A23V2002/00 , A23V2200/00 , A61K8/60 , A61K8/64 , A61K8/73 , A61K31/716 , A61K2800/10 , A61Q19/00 , C08B37/0009 , C08L5/00 , C08L5/02 , C11D3/22 , C12N9/1051 , C12P19/04 , C12P19/18 , C12Y204/00 , C12Y204/01 , C12Y204/01005 , C12Y302/01 , A23V2200/32 , A23V2200/3202 , A23V2200/328 , A23V2250/00 , A23V2250/282 , A23V2250/284 , A23V2250/5116
摘要: Disclosed herein are proteins capable of forming glucans having alpha-1,2 linkages/branches, reactions and methods for producing such glucan, compositions comprising such glucan, and various applications thereof.
-
公开(公告)号:EP2805625B1
公开(公告)日:2018-10-03
申请号:EP14181368.3
申请日:2006-02-28
申请人: N.V. Nutricia
发明人: Knol, Jan , Haarman, Monique , Garssen, Johan , Vriesema, Adrianus Johannes Maria , Alles, Martine Sandra
IPC分类号: A23L33/21 , A23L33/10 , A23L33/135 , A61K31/715 , A61P1/12 , A61P37/08
CPC分类号: A23L1/296 , A23L1/3014 , A23L1/308 , A23L33/135 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2220/63 , A23Y2300/29 , A61K9/0095 , A61K31/715 , A61K35/742 , A61K35/745 , A61K35/747 , A23V2200/3202 , A23V2250/5062 , A23V2200/3204 , A23V2200/304 , A23V2200/328 , A61K2300/00
摘要: A composition comprising 5 to 16 en.% protein, 30 to 60 en.% fat, and 25 to 75 en.% carbohydrates and comprising Bifidobacterium breve and Lactobacillus paracasei and the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.
-
公开(公告)号:EP3377082A1
公开(公告)日:2018-09-26
申请号:EP16801036.1
申请日:2016-11-21
发明人: MULDER, Imke Elisabeth , HOLT, Amy Beth , MCCLUSKEY, Seanin Marie , LENNON, Grainne Clare , AHMED, Suaad
IPC分类号: A61K35/744 , A61P35/00 , A61P29/00 , A61P37/00
CPC分类号: A61K35/74 , A23C9/1585 , A23L33/135 , A23V2002/00 , A61K9/0053 , A61K9/19 , A61K9/50 , A61K35/744 , A61K39/09 , A61K2035/11 , A61K2039/52 , A61K2039/585
摘要: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
-
36.
公开(公告)号:EP3377081A1
公开(公告)日:2018-09-26
申请号:EP16820010.3
申请日:2016-11-17
申请人: Probiotical S.p.A.
发明人: MOGNA, Giovanni
IPC分类号: A61K35/74 , A23L33/135 , A61K35/00
CPC分类号: A61K35/745 , A23L33/135 , A61K35/744 , A61K2035/115 , A61P21/00 , A61K2300/00
摘要: The present invention relates to a bacterial composition which can be effectively used in the field of sport nutrition, since it is capable of attenuating the decline in sport performance in a subject after a muscle-damaging exercise.
-
公开(公告)号:EP2442814B1
公开(公告)日:2018-09-26
申请号:EP10730548.4
申请日:2010-06-18
发明人: BURCELIN, Rémy , CARCANO, Didier , LAHTINEN, Sampo
IPC分类号: A61K31/65 , A61K35/747 , A61K31/155 , A23C9/123 , A61K31/715 , A61P3/04 , A61P5/50
CPC分类号: A61K35/745 , A23C9/123 , A23L33/135 , A23V2002/00 , A23Y2300/21 , A61K31/155 , A61K31/715 , A61K35/747 , A61K45/06 , A61K2035/115 , A61K2300/00 , A61P3/04 , A61P5/50 , Y02A50/463 , A23V2200/328 , A23V2200/332 , A23V2200/324 , A23V2200/326
摘要: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabets), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.
-
公开(公告)号:EP3363446A1
公开(公告)日:2018-08-22
申请号:EP18153975.0
申请日:2016-11-21
IPC分类号: A61K35/744 , C12N1/00 , A61P35/00
CPC分类号: A61K35/74 , A23C9/1585 , A23L33/135 , A23V2002/00 , A61K9/19 , A61K31/739 , A61K35/744 , A61K39/09 , A61K45/06 , A61K2035/11 , A61K2039/585 , C12N1/20 , C12R1/46
摘要: The invention provides compositions comprising bacterial strains for treating and preventing cancer.
-
39.
公开(公告)号:EP3351616A1
公开(公告)日:2018-07-25
申请号:EP16846783.5
申请日:2016-09-06
发明人: KIM, Dong Hyun , HAN, Myung Joo
IPC分类号: C12N1/20 , A23L33/135 , A61K35/747 , A61K35/745 , C12R1/225 , C12R1/24
CPC分类号: C12R1/225 , A23L33/135 , A23V2002/00 , A23Y2220/43 , A61K35/747 , A61K36/48 , A61P25/28 , C12N1/20 , C12R1/24
摘要: The present invention provides a novel lactobacillus and a use for same, the lactobacillus being separated from kimchi and thus highly safe, and having various types of biological activity such as memory improving activity, tight junction protein expression inducing activity, antioxidation activity, lipopolysaccharide (LPS) generation-suppressing activity, and β-glucuronidase inhibiting activity. The novel lactobacillus according to the present invention may be used as a functional food medicine material for preventing, improving, or treating degenerative brain diseases or cognitive function disorders.
-
公开(公告)号:EP3253215A4
公开(公告)日:2018-07-18
申请号:EP16740751
申请日:2016-01-21
申请人: INTRALYTIX INC
CPC分类号: C12N7/00 , A01N63/00 , A23B4/22 , A23L3/3463 , A23L3/3571 , A23L33/135 , A23V2002/00 , A61K35/742 , A61K35/744 , A61K35/745 , A61K35/747 , A61K35/76 , A61K2035/115 , C12N2795/00021 , C12N2795/00031 , C12N2795/00032 , Y02A50/406 , Y02A50/475 , A61K2300/00 , A23V2200/324
摘要: The present invention is directed to isolated bacteriophages having specificity and lytic activity against strains of Shigella species, methods of using the bacteriophages, progeny and derivatives derived therefrom, to control the growth of Shigella species in various settings (e.g., food safety, sanitation, modulating microbiome, prebiotics, probiotics).
-
-
-
-
-
-
-
-
-